On April 30, 2015, the pCODR Expert Review Committee (pERC) issued initial recommendations for Romi
Jun 14 2015
The 2015 Congress provided a forum for presenting original unpublished data and sharing ideas for hematological innovation as well as disseminating evidence-based knowledge of primary clinical relevance.
Jun 12 2015
On June 12, 2015, Hungry Brew Hops hosted a tap-takeover event where they presented Lymphoma Canada with a $2,000 cheque from their fundraising initiatives.
Jun 03 2015
In response to yesterday's publication of the new reimbursable drugs list, the Coalition Priorité Cancer au Québec is asking the Minister of Health and Social Services to speed up revision of the new drugs evaluation and listing process.
Jun 02 2015
People in Quebec living with Chronic Lymphocytic Leukemia (CLL) will now be able to access a new treatment option through the province's prescription drug insurance plan.
Jun 01 2015
Burkitt’s lymphoma (BL) is a type of non-Hodgkin lymphoma. It is characterized by a mutation in a gene called myc, which triggers the BL cells to grow uncontrollably. However, much is still unknown about the cause of the disease.
May 27 2015
Managing the Side Effects of Chemotherapy
May 21 2015
This award recognizes a CANO/ACIO member whose actions support the concept of patient advocacy and decision making, or who promotes change within the oncology/hematology communities.
May 01 2015
Apr 08 2015
Health Canada approves ZYDELIG™ (idelalisib) for treatment of relapsed chronic lymphocyctic leukemia and conditionally approves ZYDELIG™ for follicular lymphoma.